Etienne Drouet has been appointed vice president, strategic development at SynteractHCR, a full-service, international CRO. This new position was created to augment company’s oncology and complex trial expertise serving the small and mid-size biopharma segment. Mr. Drouet also joins the senior management team.   Mr. Drouet has more than 20 years of experience in executive leadership, program and project management, clinical trial management, and R&D within the contract research and biopharma...